{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:55:11Z","timestamp":1788508511641,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI16C0992"],"award-info":[{"award-number":["HI16C0992"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","heartrhythmjournal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.hrthm.2018.06.044","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T14:19:35Z","timestamp":1530627575000},"page":"1825-1832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Rate control and clinical outcomes in patients with atrial fibrillation and obstructive lung disease"],"prefix":"10.1016","volume":"15","author":[{"given":"Seng Chan","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ho","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dukyong","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga-Young","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pil-Sung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Tae","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae Woong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyoung","family":"Joung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2018.06.044_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.gheart.2014.01.004","article-title":"Global burden of atrial fibrillation in developed and developing nations","volume":"9","author":"Chugh","year":"2014","journal-title":"Glob Heart"},{"key":"10.1016\/j.hrthm.2018.06.044_bib2","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Causes of Death C. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Mortality","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2018.06.044_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jjcc.2016.12.013","article-title":"Chronic obstructive pulmonary disease and atrial fibrillation: An unknown relationship","volume":"69","author":"Goudis","year":"2017","journal-title":"J Cardiol"},{"key":"10.1016\/j.hrthm.2018.06.044_bib4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.7150\/ijms.8.514","article-title":"Impairment of pulmonary function is an independent risk factor for atrial fibrillation: the Takahata study","volume":"8","author":"Shibata","year":"2011","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.hrthm.2018.06.044_bib5","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/CIRCULATIONAHA.113.004050","article-title":"Airflow obstruction, lung function, and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study","volume":"129","author":"Li","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2018.06.044_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/europace\/eut255","article-title":"Reduced forced expiratory volume is associated with increased incidence of atrial fibrillation: the Malmo Preventive Project","volume":"16","author":"Johnson","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2018.06.044_bib7","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.amjcard.2015.03.018","article-title":"Ability of reduced lung function to predict development of atrial fibrillation in persons aged 45 to 84 years (from the Multi-Ethnic Study of Atherosclerosis-Lung Study)","volume":"115","author":"Chahal","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2018.06.044_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ahj.2016.08.011","article-title":"Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry","volume":"181","author":"Proietti","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2018.06.044_bib9","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2018.06.044_bib10","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2018.06.044_bib11","doi-asserted-by":"crossref","first-page":"e001611","DOI":"10.1161\/JAHA.114.001611","article-title":"Beta-blocker use and mortality in COPD patients after myocardial infarction: a Swedish nationwide observational study","volume":"4","author":"Andell","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2018.06.044_bib12","doi-asserted-by":"crossref","first-page":"f55","DOI":"10.1136\/bmj.f55","article-title":"Benefits of beta blockers in patients with heart failure and reduced ejection fraction: network meta-analysis","volume":"346","author":"Chatterjee","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2018.06.044_bib13","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1161\/STROKEAHA.117.018551","article-title":"CHA2DS2-VASc score for identifying truly low-risk atrial fibrillation for stroke: a Korean Nationwide Cohort Study","volume":"48","author":"Kim","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2018.06.044_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2466-13-51","article-title":"Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study","volume":"13","author":"Kim","year":"2013","journal-title":"BMC Pulmon Med"},{"key":"10.1016\/j.hrthm.2018.06.044_bib15","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.rmed.2011.06.012","article-title":"COPD in the general population: prevalence, incidence and survival","volume":"105","author":"Afonso","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.hrthm.2018.06.044_bib16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.hrthm.2018.06.044_bib17","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijcard.2014.07.087","article-title":"The association of asthma and atrial fibrillation--a nationwide population-based nested case-control study","volume":"176","author":"Chan","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2018.06.044_bib18","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jamda.2014.04.009","article-title":"Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study","volume":"15","author":"Huang","year":"2014","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.hrthm.2018.06.044_bib19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0735-1097(96)00592-X","article-title":"Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies","volume":"29","author":"Shinbane","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2018.06.044_bib20","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1161\/CIRCULATIONAHA.111.019919","article-title":"Rate control in atrial fibrillation: targets, methods, resynchronization considerations","volume":"124","author":"Heist","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2018.06.044_bib21","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/imj.13240","article-title":"Beta-blockers are under-prescribed in patients with chronic obstructive pulmonary disease and co-morbid cardiac disease","volume":"46","author":"Neef","year":"2016","journal-title":"Intern Med J"},{"key":"10.1016\/j.hrthm.2018.06.044_bib22","doi-asserted-by":"crossref","first-page":"d2549","DOI":"10.1136\/bmj.d2549","article-title":"Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study","volume":"342","author":"Short","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2018.06.044_bib23","doi-asserted-by":"crossref","first-page":"e113048","DOI":"10.1371\/journal.pone.0113048","article-title":"Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies","volume":"9","author":"Du","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2018.06.044_bib24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinternmed.2010.112","article-title":"Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease","volume":"170","author":"Rutten","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrthm.2018.06.044_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40749-015-0013-y","article-title":"Beta-blockers in patients with chronic obstructive disease and coexistent cardiac illnesses","volume":"1","author":"Puente-Maestu","year":"2015","journal-title":"COPD Res Pract"},{"key":"10.1016\/j.hrthm.2018.06.044_bib26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/0003-4819-137-9-200211050-00035","article-title":"Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis","volume":"137","author":"Salpeter","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2018.06.044_bib27","first-page":"CD003566","article-title":"Cardioselective beta-blockers for chronic obstructive pulmonary disease","author":"Salpeter","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hrthm.2018.06.044_bib28","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1177\/030006051204000602","article-title":"Use of cardioselective beta-blockers in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized, placebo-controlled, blinded trials","volume":"40","author":"Ni","year":"2012","journal-title":"J Int Med Res"},{"key":"10.1016\/j.hrthm.2018.06.044_bib29","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/jch.12204","article-title":"Beta-blockers and chronic obstructive pulmonary disease: inappropriate avoidance?","volume":"15","author":"Minor","year":"2013","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.hrthm.2018.06.044_bib30","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jacc.2003.11.032","article-title":"The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation","volume":"43","author":"Olshansky","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2018.06.044_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jacc.2006.08.046","article-title":"Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure","volume":"49","author":"Le Jemtel","year":"2007","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527118306702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527118306702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T23:05:11Z","timestamp":1571785511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527118306702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1547527118306702"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2018.06.044","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rate control and clinical outcomes in patients with atrial fibrillation and obstructive lung disease","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2018.06.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}